The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2
Open accessAbstract
Inflammation associates with peripheral insulin resistance, which dysregulates nutrient homeostasis and leads to diabetes. Inflammation induces the expression of SOCS proteins. We show that SOCS1 or SOCS3 targeted IRS1 and IRS2, two critical signaling molecules for insulin action, for ubiquitin-mediated degradation. SOCS1 or SOCS3 bound both recombinant and endogenous IRS1 and IRS2 and promoted their ubiquitination and subsequent degradation in multiple cell types. Mutations in the conserved SOCS box of SOCS1 abrogated its interaction with the elongin BC ubiquitin-ligase complex without affecting its binding to IRS1 or IRS2. The SOCS1 mutants also failed to promote the ubiquitination and degradation of either IRS1 or IRS2. Adenoviral-mediated expression of SOCS1 in mouse liver dramatically reduced hepatic IRS1 and IRS2 protein levels and caused glucose intolerance; by contrast, expression of the SOCS1 mutants had no effect. Thus, SOCS-mediated degradation of IRS proteins, presumably via the elongin BC ubiquitin-ligase, might be a general mechanism of inflammation-induced insulin resistance, providing a target for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“obesity-related insulin resistance could result from a diminution in insulin receptor substrate-1 (IRS-1) in animals, secondary to an increase in suppressor of cytokine signaling 3 (SOCS-3), which binds to IRS-1 and leads to its ubiquitylation and proteolysis in experimental animals [5]”
From Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects (2020) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H. H., Burks, D. J., Ren, J., Previs, S. F., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
SOCS Proteins: Negative Regulators of Cytokine Signaling
Krebs, D. L., & Hilton, D. J. (2001) · Stem Cells · doi:10.1634/stemcells.19-5-378 · Cited by 826
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 688
Zhang, J., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., Moritz, R. L., Cary, D., Richardson, R. T., Hausmann, G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2071 · Cited by 626
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 899
Molecular and Signaling Mechanisms of Atherosclerosis in Insulin Resistance
Schwartz, E. A., & Reaven, P. D. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.005 · Cited by 39
Lutz, S. Z., Hennige, A. M., Feil, S. C., Peter, A., Gerling, A., Machann, J., Kröber, S. M., Rath, M., Schürmann, A., Weigert, C., et al. (2011) · Diabetes · doi:10.2337/db10-0760 · Cited by 41
Immunometabolic role of long‐chain omega‐3 fatty acids in obesity‐induced inflammation
Flock, M. R., Rogers, C. J., Prabhu, K. S., & Kris‐Etherton, P. M. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2414 · Cited by 43
Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field
Dave, N., Wu, J., & Thomas, S. S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1010-8 · Cited by 39
Cancer as a homeostatic challenge: the role of the hypothalamus
Francis, N., & Borniger, J. C. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.08.008 · Cited by 42
Sopasakis, V. R., Larsson, B.-M., Johansson, A., Holm�ng, A., & Smith, U. (2004) · Diabetologia · doi:10.1007/s00125-004-1544-y · Cited by 40
Warren, K. J., Fang, X., Gowda, N. M., Thompson, J. J., & Heller, N. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756791 · Cited by 38
Zheng, S., & Tao, W. (2021) · Cancers · doi:10.3390/cancers13051013 · Cited by 38
Phosphorylation of Irs1 at SER-522 Inhibits Insulin Signaling
Giraud, J., Haas, M., Feener, E. P., Copps, K. D., Dong, X. C., Dunn, S. L., & White, M. F. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0159 · Cited by 38
The serine phosphorylations in the IRS-1 PIR domain abrogate IRS-1 and IR interaction
Woo, J. R., Bae, S.-H., Wales, T. E., Engen, J. R., Lee, J., Jang, H., & Park, S. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2401716121 · Cited by 41
Bruun, C., Heding, P. E., Rønn, S. G., Frobøse, H., Rhodes, C. J., Mandrup-Poulsen, T. R., & Billestrup, N. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.019 · Cited by 37
Lee, H., Jee, Y., Hong, K., Hwang, G. S., & Chun, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083471 · Cited by 38
Egr2 enhances insulin resistance via JAK2/STAT3/SOCS-1 pathway in HepG2 cells treated with palmitate
Lü, L., Ye, X., Yao, Q., Lu, A., Zhao, Z., Ding, Y., Meng, C., Yu, W., Du, Y., & Cheng, J. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.08.023 · Cited by 37
Williams, J. J. L., Munro, K. M., & Palmer, T. M. (2014) · Cells · doi:10.3390/cells3020546 · Cited by 38
Sepsis-induced SOCS-3 expression is immunologically restricted to phagocytes
Grutkoski, P. S., Chen, Y., Chung, C., & Ayala, A. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303108 · Cited by 37
Interleukin-Targeted Therapy for Metabolic Syndrome and Type 2 Diabetes
Maedler, K., Dharmadhikari, G., Schumann, D., & Størling, J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_11 · Cited by 37
Xu, Z., Nie, Q., & Zhang, X. (2013) · Current Genomics · doi:10.2174/1389202911314020006 · Cited by 36
Inagaki-Ohara, K., Sasaki, A., Matsuzaki, G., Ikeda, T., Hotokezaka, M., Chijiiwa, K., Kubo, M., Yoshida, H., Nawa, Y., & Yoshimura, A. (2005) · Gut · doi:10.1136/gut.2004.062653 · Cited by 36
Makwana, K., Patel, S. A., Velingkaar, N., Ebron, J. S., Shukla, G. C., & Kondratov, R. V. (2017) · Aging · doi:10.18632/aging.101270 · Cited by 37
Long, M., Zhang, C., Xu, D., Fu, W., Gan, X., Li, F., Wang, Q., Xia, W., & Xu, D. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113342 · Cited by 35
Causal network inference from gene transcriptional time-series response to glucocorticoids
Lu, J., Dumitrascu, B., McDowell, I. C., Jo, B., Barrera, A., Hong, L. K., Leichter, S. M., Reddy, T. E., & Engelhardt, B. E. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008223 · Cited by 35
The Insulin Receptor: An Important Target for the Development of Novel Medicines and Pesticides
Zhang, X., Zhu, X.-Z., Bi, X., Huang, J., & Zhou, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147793 · Cited by 40
Witasp, A., Nordfors, L., Schalling, M., Nygren, J., Ljungqvist, O. H., & Thorell, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2588 · Cited by 35
Bayle, J., Lopez, S., Iwaï, K., Dubreuil, P. C., & Sepulveda, P. D. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.093 · Cited by 35
Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis
Başaranoğlu, M. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i36.4055 · Cited by 35
Yoshihara, H., Fukushima, T., Hakuno, F., Saeki, Y., Tanaka, K., Ito, A., Yoshida, M., Iemura, S., Natsume, T., Asano, T., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.093 · Cited by 35
Levine, J. A., Han, J. M., Wolska, A. T., Wilson, S. R., Patel, T. P., Remaley, A. T., Periwal, V., Yanovski, J. A., & Demidowich, A. P. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.07.012 · Cited by 35
Evidence for a regulatory role of Cullin-RING E3 ubiquitin ligase 7 in insulin signaling
Scheufele, F., Wolf, B., Kruse, M., Hartmann, T., Lempart, J., Muehlich, S., Pfeiffer, A. F. H., Field, L. J., Charron, M. J., Pan, Z., et al. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.005 · Cited by 35
Tuberous Sclerosis and Insulin Resistance: Unlikely Bedfellows Reveal A TORrid Affair
Shah, O. J., & Hunter, T. R. (2004) · Cell Cycle · doi:10.4161/cc.4.1.1343 · Cited by 34
Congur, I., Mingrone, G., & Guan, K. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156062 · Cited by 33
Diabetic cardiomyopathy: role of the E3 ubiquitin ligase
Bai, T., Wang, F., Mellen, N. M., Zheng, Y., & Cai, L. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00467.2015 · Cited by 33
Ubiquitylation Pathways In Insulin Signaling and Organismal Homeostasis
Balaji, V., Pokrzywa, W., & Hoppe, T. (2018) · BioEssays · doi:10.1002/bies.201700223 · Cited by 33
Expression Pattern of microRNAs, miR-21, miR-155 and miR-338 in Patients with Type 1 Diabetes
Mostahfezian, M., Azhir, Z., Dehghanian, F., & Hojati, Z. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.07.002 · Cited by 32
Hypothalamic Leptin Receptor and Signaling Molecule Expressions in Cafeteria Diet-Fed Rats
Plut, C., Ribière, C., Giudicelli, Y., & Dausse, J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054726 · Cited by 33
Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1
Parnell, E., McElroy, S. P., Wiejak, J., Baillie, G. L., Porter, A., Adams, D. R., Rehmann, H., Smith, B. O., & Yarwood, S. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00455-7 · Cited by 32
Zhao, H., Lu, J., He, F., Wang, M., Yan, Y., Chen, B., Xie, D., Xu, C., Wang, Q., Liu, W., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931087 · Cited by 31
Cullin RING Ligase 5 (CRL-5): Neddylation Activation and Biological Functions
Zhang, S., & Sun, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_16 · Cited by 31
Xu, T., Xu, L., Meng, P., Ma, X., Yang, X., Zhou, Y., & Feng, M. (2020) · The FASEB Journal · doi:10.1096/fj.202000246rr · Cited by 32
REDD1 promotes obesity-induced metabolic dysfunction via atypical NF-κB activation
Lee, D., Kim, T., Byeon, J., Park, M., Kim, S., Kim, J., Choi, S., Lee, G., Park, C., Lee, K. W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34110-1 · Cited by 35
Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo
Pereira, S., Park, E., Moore, J., Faubert, B., Breen, D. M., Oprescu, A. I., Nahle, A., Kwan, D., Giacca, A., & Tsiani, E. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0075 · Cited by 34
Xu, X., Keshwani, M. M., Meyer, K. R., Sarikas, A., Taylor, S. S., & Pan, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.405209 · Cited by 33
Suppressor of Cytokine Signaling 3 Inhibits Breast Tumor Kinase Activation of STAT3
Gao, Y., Cimica, V., & Reich, N. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334144 · Cited by 33
Linking obesity with type 2 diabetes: the role of T-bet
Sutherland, A. P. R., Wali, J. A., & Thomas, H. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s51432 · Cited by 34
Zhang, L. R., Xu, J., Song, H., Yao, Z., & Ji, G. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0236-8 · Cited by 31
Chemical Genetic Identification of the IGF-Linked Pathway that Is Mediated by STAT6 and MFP2
Choi, Y., Shimogawa, H., Murakami, K., Ramdas, L., Zhang, W., Qin, J., & Uesugi, M. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.12.011 · Cited by 31
Amino acid-induced impairment of insulin sensitivity in healthy and obese rats is reversible
Jeganathan, S., Abdullahi, A., Zargar, S., Maeda, N., Riddell, M. C., & Adegoke, O. A. J. (2014) · Physiological Reports · doi:10.14814/phy2.12067 · Cited by 29
Macrophage CGI-58 deficiency promotes IL-1β transcription by activating the SOCS3–FOXO1 pathway
Miao, H., Ou, J., Zhang, X., Chen, Y., Xue, B., Shi, H., Gan, L., Yu, L., & Liang, H. (2014) · Clinical Science · doi:10.1042/cs20140414 · Cited by 31
Effects of periodontitis on aortic insulin resistance in an obese rat model
Ekuni, D., Tomofuji, T., Irie, K., Kasuyama, K., Umakoshi, M., Azuma, T., Tamaki, N., Sanbe, T., Endo, Y., Yamamoto, T., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2009.141 · Cited by 31
The suppressor of cytokine signaling (SOCS)-7 interacts with the actin cytoskeleton through vinexin
Martens, N., Wéry, M., Wang, P., Braet, F., Gertler, A., Hooghe, R. J., Vandenhaute, J., & Hooghe-Peters, E. L. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.002 · Cited by 32
Reduced insulin receptor signaling in retinal Müller cells cultured in high glucose.
Jiang, Y., Pagadala, J., Miller, D. D., & Steinle, J. J. (2013) · Europe PMC (PubMed Central) · Cited by 31
Mandrup-Poulsen, T. R. (2013) · Dermatologic Clinics · doi:10.1016/j.det.2013.04.006 · Cited by 31
Morel, C., Standen, C. L., Jung, D. Y., Gray, S., Ong, H., Flavell, R. A., Kim, J. K., & Davis, R. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00585-10 · Cited by 30
Lebrun, P., Cognard, E., Paul, R., Gontard, P., Filloux, C., Jehl-Piétri, C., Grimaldi, P. A., Samson, M., Pénicaud, L., Ruberte, J., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1474-9 · Cited by 31
Khan, M. G. M., Ghosh, A., Variya, B. C., Santharam, M. A., Ihsan, A. U., Ramanathan, S., & Ilangumaran, S. (2020) · BMC Cancer · doi:10.1186/s12885-020-07285-3 · Cited by 31
Chen, J., Zhu, J., & Meng, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104258 · Cited by 30
Rastmanesh, M. M., Bluyssen, H. A. R., Joles, J. A., de Boer, P., Willekes-Koolschijn, N., & Braam, B. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.013 · Cited by 30
van de Loo, F. A. J., Veenbergen, S., van den Brand, B. T., Bennink, M. B., Blaney‐Davidson, E., Arntz, O. J., van Beuningen, H. M., van der Kraan, P. M., & van den Berg, W. B. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34529 · Cited by 30
Zhao, H., Huang, X., Jiao, J., Zhang, H., Liu, J., Qin, W., Meng, X., Shen, T., Lin, Y., Chu, J., et al. (2015) · Scientific Reports · doi:10.1038/srep18093 · Cited by 30
Li, J.-Y., Chai, B.-X., Zhang, W., Liu, Y.-Q., Ammori, J. B., & Mulholland, M. W. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.12.010 · Cited by 30
Alikhah, A., Kakhki, M. P., Ahmadi, A., Dehghanzad, R., Boroumand, M. A., & Behmanesh, M. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.12.001 · Cited by 29
Khodarahmi, A., Eshaghian‐dorcheh, A., Safari, F., & Moradi, A. (2019) · Journal of Food Science · doi:10.1111/1750-3841.14793 · Cited by 29
Chen, C., Gu, L., Matye, D. J., Clayton, Y., Hasan, M. N., Wang, Y., Friedman, J. E., & Li, T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111737119 · Cited by 29
Transcription factor AP-2β: A negative regulator of IRS-1 gene expression
Meng, X., Kondo, M., Morino, K., Fuke, T., Obata, T., Yoshizaki, T., Ugi, S., Nishio, Y., Maeda, S., Araki, E., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.056 · Cited by 29
Zhang, L., Song, H., Ying-li, G. E., Ji, G., & Yao, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117008 · Cited by 33
Ceschin, D. G., Sanchez, M. C., & Chiabrando, G. A. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22014 · Cited by 29
JAK-STAT signaling and myocardial glucose metabolism
Frias, M. A., & Montessuit, C. (2013) · JAK-STAT · doi:10.4161/jkst.26458 · Cited by 30
de Almeida-Faria, J., Duque-Guimaraes, D. E., Carpenter, A. A. M., Loche, E., & Ozanne, S. E. (2017) · Scientific Reports · doi:10.1038/srep44949 · Cited by 32
Lipocalin 13 regulation of glucose and lipid metabolism in obesity
Zhou, Y., & Rui, L. (2013) · Vitamins & Hormones · doi:10.1016/b978-0-12-407766-9.00015-8 · Cited by 28
Self-citationMuscle wasting: An overview of recent developments in basic research
Palus, S., von Haehling, S., & Springer, J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.086 · Cited by 29
Insulin Resistance and Insulin Handling in Chronic Kidney Disease
Parvathareddy, V. P., Wu, J., & Thomas, S. S. (2023) · Comprehensive physiology · doi:10.1002/j.2040-4603.2023.tb00281.x · Cited by 28
Ando, Y., Shinozawa, Y., Iijima, Y., Yu, B., Sone, M., Ooi, Y., Watanaka, Y., Chida, K., Hakuno, F., & Takahashi, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624759 · Cited by 28
Suppressors of cytokine signaling (SOCS) and type 2 diabetes
Feng, X., Tang, H., Leng, J., & Jiang, Q. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3079-8 · Cited by 28
Gylvin, T., Nolsöe, R. L. M., Hansen, T. F., Nielsen, E., Bergholdt, R., Karlsen, A. E., Billestrup, N., Borch‐Johnsen, K., Pedersen, O. B., Mandrup-Poulsen, T. R., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1440-5 · Cited by 28
Kuźmicki, M., Telejko, B., Wawrusiewicz‐Kurylonek, N., Citko, A., Lipińska, D., Pliszka, J., Wilk, J., Kalejta, K., Lemancewicz, A., Grabiec, M., et al. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.683055 · Cited by 28
Neukamm, S. S., Ott, J., Dammeier, S., Lehmann, R., Häring, H., Schleicher, E. D., & Weigert, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.474593 · Cited by 28
Elliott, J., Suessmuth, Y., Scott, L. M., Nahlik, K., McMullin, M. F., Constantinescu, S. N., Green, A. R., & Johnston, J. A. (2009) · Haematologica · doi:10.3324/haematol.2008.002352 · Cited by 28
Unveil the transcriptional landscape at the Cryptococcus-host axis in mice and nonhuman primates
Li, H., Li, Y., Sun, T., Du, W., Li, C., Suo, C., Meng, Y., Liang, Q., Lan, T., Zhong, M., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007566 · Cited by 29
Eichner, R., Fernández‐Sáiz, V., Targosz, B., & Bassermann, F. C. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.06.001 · Cited by 27
Chen, W.-B., Gao, L., Wang, J., Wang, Y.-G., Dong, Z., Zhao, J., Mi, Q., & Zhou, L. (2016) · Oncotarget · doi:10.18632/oncotarget.11295 · Cited by 27
Sun, W., Sun, J., Zhang, B., Xing, Y., Yu, X., Li, X., Xiu, Z., & Dong, Y. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.08.005 · Cited by 27
PPARγ alleviated hepatocyte steatosis through reducing SOCS3 by inhibiting JAK2/STAT3 pathway
Bi, J., Sun, K., Wu, H., Chen, X., Tang, H., & Mao, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.110 · Cited by 28
Naudin, C., Chevalier, C., & Roche, S. (2016) · Oncotarget · doi:10.18632/oncotarget.6929 · Cited by 33
Alves-Silva, T., Freitas, G., Húngaro, T., Arruda, A., Oyama, L., Avellar, M. C. W., & Araújo, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-90872-6 · Cited by 24
Therapeutic Effects of Suppressors of Cytokine Signaling in Diabetic Nephropathy
Liu, Q., Xing, L., Wang, L., Yao, F., Liu, S., Hao, J., Liu, W., & Duan, H. (2013) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413512493 · Cited by 26
RETRACTED ARTICLE: SOCS3 inhibits insulin signaling in porcine primary adipocytes
Yang, S., Xu, C.-Q., Wu, J. W., & Yang, G.-S. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0558-7 · Cited by 27
RetractedProtein kinase C-δ is involved in the inflammatory effect of IL-6 in mouse adipose cells
Wallerstedt, E., Smith, U., & Andersson, C. X. (2010) · Diabetologia · doi:10.1007/s00125-010-1668-1 · Cited by 27
Zolotnik, I. A., Figueroa, T. Y., & Yaspelkis, B. B. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.08.038 · Cited by 26
Oh, J., Kim, S.-H., Ahn, S., & Lee, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103415 · Cited by 27
Franch, H. A., & Mitch, W. E. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141051 · Cited by 26
SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus
Zhan, Y., Davey, G. M., Graham, K. L., Kiu, H., Dudek, N. L., Kay, T. W. H., & Lew, A. M. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.23 · Cited by 25
Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats
Eshaghian‐dorcheh, A., Khodarahmi, A., Safari, F., Binesh, F., & Moradi, A. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518001095 · Cited by 26
Zhang, L., Xu, C., Chen, X., Shi, Q., Su, W., & Zhao, H. (2018) · Inflammation · doi:10.1007/s10753-018-0802-y · Cited by 26
Cui, X., Shan, X., Qian, J., Ji, Q., Wang, L., Wang, X., Li, M., Ding, H., Liu, Q., Chen, L., et al. (2016) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2016.05.011 · Cited by 27
Das, S. R., & Choudhuri, D. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117560 · Cited by 27
MG53 is not a critical regulator of insulin signaling pathway in skeletal muscle
Philouze, C., Turban, S., Cremers, B., Caliez, A., Lamarche, G., Bernard, C., Provost, N., & Delerive, P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245179 · Cited by 24
Piao, L., Park, J., Li, Y., Shin, S., Shin, S., Kong, G., SHRESTHA, R., Tran, Q., Hur, G. M., Kim, J. L., et al. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1693 · Cited by 27
SOCS and diabetes—ups and downs of a turbulent relationship
Suchy, D., Łabuzek, K., Machnik, G., Kozłowski, M., & Okopień, B. (2013) · Cell Biochemistry and Function · doi:10.1002/cbf.2940 · Cited by 27
Resistin induces insulin resistance, but does not affect glucose output in rat-derived hepatocytes
Liu, F., Yang, T., Wang, B., Zhang, M., Gu, N., Qiu, J., Fan, H., Zhang, C., Li, F., Pan, X.-Q., et al. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00709.x · Cited by 25
Insulin Resistance and Insulin Handling in Chronic Kidney Disease
Parvathareddy, V. P., Wu, J., & Thomas, S. S. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220019 · Cited by 54
Qin, S., Sun, D., Mu, J., Ma, D., Tang, R., & Zheng, Y. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.025 · Cited by 24
Metadata
- Authors
- Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- White, Morris F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 44
- Pages
- 42394-42398
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2069711307
- Cited by
- 904
- References
- 44
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 18 · 2023: 25 · 2022: 35 · 2021: 39 · 2020: 27 · 2019: 29 · 2018: 42 · 2017: 33 · 2016: 48 · 2015: 27 · 2014: 50 · 2013: 51 · 2012: 57
- FWCI
- 30.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- SOCS1, SOCS3, IRS-1, insulin receptor substrate 2, insulin signaling, ubiquitin-mediated proteolysis, SOCS box, inflammation, insulin resistance, impaired glucose tolerance, liver, diabetes mellitus
- MeSH terms
- Suppressor of Cytokine Signaling 1 Protein, Suppressor of Cytokine Signaling 3 Protein, Elongin, Animals, Carrier Proteins, Glucose, Homeostasis, Humans, Insulin Resistance, Male, Mice, Inbred C57BL, Phosphoproteins, Proteins, Repressor Proteins, Transcription Factors, Ubiquitin, Intracellular Signaling Peptides and Proteins, Suppressor of Cytokine Signaling Proteins, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review